Daval, Joname B.
HRN: 21-64-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
07/25/2022
08/01/2022
PO
3ml
Bid
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes